Navigation Links
OPERON® B 710 Surgical Table

ProductsOPERON® B 710 Surgical Table
Company Berchtold Corporation
Item OPERON® B 710 Surgical Table
Features 
  • Full body imaging capabilities with superior C-arm coverage accommodates most surgical procedures.
  • Convenient pass-through x-ray channel eliminates the need for cumbersome x-ray table tops.
  • Maximum Imaging access reduces set up time, increases case turnover efficiency, and provides for better clinical decision making, easier procedural access, and optimal patient care.
Description For unmatched versatility and positioning, look to BERCHTOLD's OPERON B 710 Surgical Table. Our 5-section modular design and 770 lb. weight capacity ensures configurations for a wide variety of surgical specialties and patient sizes. The radiolucent phenolic tabletop provides superior imaging capabilities, easily accessed with a C-arm. An intuitive remote control with one touch commands, large double swivel casters and a 28" to 44" vertical articulation range offers precise, ergonomic positioning.
Info Berchtold Corporation
Customer Service: (843) 569-6100
Web site: http://www.berchtold.de

Related medicine products :

1. No.12 Surgical Blade
2. No. SM68 Surgical Blade
3. Surgiscribe Surgical Marking Pens
4. Surgical Markers
5. TLS Surgical Markers
6. SQUEEZE-MARK Surgical Markers
7. Ultra MD40 Super Pulse CO2 Surgical Laser
8. Ultra MD 60 Super Pulse CO2 Surgical Laser
9. Ultra MD 80 Super Pulse CO2 Surgical Laser
10. Reliance Mobile Surgical Stretcher
11. Ocular Posner Diagnostic And Surgical Gonioprism
... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
Medicine Products:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: